Why the study?
To investigate the effect of minimally invasive cardiac surgery on resource utilization, cost, and postoperative outcomes in patients undergoing left-heart valve operations.
Does minimally invasive cardiac surgery reduce high resource utilization compared to full sternotomy in patients undergoing left-heart single-valve surgery?
Does minimally invasive cardiac surgery reduce high resource utilization compared to full sternotomy in patients undergoing left-heart single-valve surgery?
Minimally invasive cardiac surgery for left-heart valve operations is associated with significantly lower resource utilization, shorter length of stay, and reduced direct costs compared to full sternotomy.
MICS was associated with lower resource use and costs after valve surgery; leaves open whether randomized data will confirm benefits.
Objective To investigate the effect of minimally invasive cardiac surgery (MICS) on resource utilization, cost, and postoperative outcomes in patients undergoing left-heart valve operations. Methods Data were retrospectively reviewed for patients undergoing single-valve surgery (eg, aortic valve replacement, mitral valve replacement, or mitral valve repair) at a single center from 2018 to 2021, stratified by surgical approach: MICS vs full sternotomy (FS). Baseline characteristics and postoperative outcomes were compared. Primary outcome was high resource utilization, defined as direct procedure cost higher than the third quartile or either postoperative LOS ≥7 days or 30-day readmission. Secondary outcomes were direct cost, length of stay, 30-day readmission, in-hospital and 30-day mortality, and major morbidity. Multiple regression analysis was conducted, controlling for baseline characteristics, operative approach, valve operation, and lead surgeon to assess high resource utilization. Results MICS was correlated with a significantly lower rate of high resource utilization (MICS, 31.25% [n = 115] vs FS 61.29% [n = 76]; P < .001). Median postoperative length of stay (MICS, 4 days [range, 3-6 days] vs FS, 6 days [range, 4 to 9 days]; P < .001) and direct cost (MICS, $22,900 [$19,500–$28,600] vs FS, $31,900 [$25,900–$50,000]; P < .001) were lower in the MICS group. FS patients were more likely to experience postoperative atrial fibrillation ( P = .040) and renal failure ( P = .027). Other outcomes did not differ between groups. Controlling for stratified Society of Thoracic Surgeons predicted risk of mortality, cardiac valve operation, and lead surgeon, FS demonstrated increased likelihood of high resource utilization ( P < .001). Conclusions MICS for left-heart valve pathology demonstrated improved postoperative outcomes and resource utilization.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: